Cystic Breast Masses by Contrast Enhanced Ultrasound (CEUS)
Completed
Conditions studied: Breast Cancer
In brief
The overarching goal of the proposed research is to evaluate whether qualitative and quantitative parameters in real time contrast enhanced ultrasound (CEUS) can aid in assessing suspicious indeterminate cystic appearing breast masses and ultimately determine whether or not an ultrasound guided biopsy is necessary. The underlying hypothesis is that breast masses (given BIRADS 4) that lack enhancement on CEUS will have a benign histology obtained by ultrasound guided core biopsy and/or surgery. Then, in the future, these non-enhancing cystic lesions can be followed and do not need biopsy intervention.
Key facts
- Study ID
- NCT02887937
- Run by
- University of Southern California
- People needed
- 135
- Starts
- 2016-08-16
- Expected to finish
- 2018-04-29
- Last updated by the study team
- 2018-05-15
Who can join
Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- >18 years of age
- recommended for an ultrasound guided biopsy due to breast mass detection
You may not qualify if…
- < 18 years of age
- prior history of breast cancer
- prior history of biopsy for that specific lesion
- any condition that would be a contraindication to the microbubble contrast agent used in CEUS such as pulmonary hypertension, 3cardiac shunts, and allergy to perflutren.
Where it is running
- USC Department of Radiology — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.